RareMed is thrilled to announce that, for the second year in a row, we have again been named a finalist in the prestigious MMIT Patient Choice Awards. This recognition marks another milestone in our ongoing commitment to delivering unparalleled patient care and support. In 2025, Team RareMed was honored have won the inaugural Patient Choice award, after delivering the highest average net promoter score amongst peers for over three years, consistently exceeding 90 points. This award and subsequent nomination are testaments to our dedication to delivering a level of patient satisfaction that sets the standard of the world.
RareMed will attend Asembia’s AXS26 conference this year, where the winner of the 2026 Patient Choice Awards will be announced. RareMed is hoping to secure back-to-back victories in the hub services category, as we continue to deliver on our vision of elevating the benchmark for patient care nationwide.
Driving Future Success
The Asembia AXS26 Conference provides a perfect platform to share our success story with industry peers and partners. It is an opportunity to highlight RareMed’s innovative strategies and dedicated teamwork that underpin our patient care philosophies. This year, RareMed will be hosting CARS AND COCKTAILS together with Pagani and McLaren Automotive at the Wynn, bringing together the industry leader that deliver the fastest, most customizable experiences in all of hub services with brands that share our commitments to excellence in the world of automobiles.
RareMed’s CARS AND COCKTAILS event will be held on Monday, April 27th, from 5:00PM to 7:30PM at the Pagani & McLaren experience center on the Wynn Fairway Esplanade between the casino and conference areas. Registration is required. Contact info@raremed.com for details. Space is limited. Join our team to explore exotic cars, racing simulators, food, and drink, while discussing the future of patient service and support.
We hope to again be able to bring an MMIT Patient Choice Award to our event to celebrate!
Patient-Centric Excellence
The MMIT Patient Choice Awards are a revered accolade in the healthcare industry, reflecting the voices and experiences of patients who benefit from specialty pharmacy and hub services. Being selected as a finalist this year underscores RareMed’s steadfast commitment to patient-centric care. Our inclusion in the top contenders for the award is based on feedback from an anonymous patient satisfaction survey, highlighting the genuine impact of our services on the lives of those we serve.
Feedback from the Frontlines
Patient satisfaction surveys play a crucial role in shaping our approach to care. These surveys offer invaluable insights into the patient experience, providing a window into what we are doing well and where there is room for improvement. The feedback we have received over the past year has been overwhelmingly positive, acknowledging our dedication to personalized support, comprehensive education, and seamless access to therapies.
Patients have praised RareMed for our compassionate approach, highlighting the meaningful relationships they develop with our patient care liaisons. The survey responses indicate that our efforts to reduce barriers to access and provide swift, effective support resonate deeply with those we serve. These insights fuel our drive to continually enhance our services and uphold the high standards that patients have come to expect from us.
Celebrating Together
We extend our heartfelt gratitude to the patients who took the time to share their experiences and feedback. Your voices are invaluable to us, and your satisfaction is the ultimate reward for our efforts. We are honored to be a part of your healthcare journey and are dedicated to evolving our services to meet your expectations.
We also acknowledge the tireless efforts of our RareMed team, whose passion and dedication make such achievements possible. Your commitment to patient care, innovation, and excellence is the driving force behind our success, and we are grateful for your contributions.
As we celebrate our status as a finalist in the 2026 MMIT Patient Choice Awards, we are reminded of the power of collaboration, compassion, and patient-centered care. RareMed is proud to be recognized for our efforts, and we remain committed to pushing the boundaries of what is possible in the specialty pharmacy sector. Together, with our patients, partners, and team members, we will continue to strive for excellence, ensuring that every interaction is marked by empathy, understanding, and a commitment to positive outcomes.
Thank you to everyone who has been a part of this journey. We look forward to celebrating more successes together and continuing to make a meaningful difference in the lives of patients worldwide.